References:
1. Attenhofer Jost CH, Connolly HM, Dearani JA, Edwards WD, Danielson GK. Ebstein’s anomaly. Circulation. 2007 Jan 16;115(2):277-85.
2. Luu Q, Choudhary P, Jackson D, Canniffe C, McGuire M, Chard R, Celermajer DS. Ebstein’s anomaly in those surviving to adult life–a single centre experience. Heart, Lung and Circulation. 2015 Oct 1;24(10):996-1001.
3. Hebe J. Ebstein’s anomaly in adults. Arrhythmias: diagnosis and therapeutic approach. The Thoracic and cardiovascular surgeon. 2000;48(04):214-9.
4. Katritsis DG, Wellens HJ, Josephson ME. Mahaim accessory pathways. Arrhythmia & electrophysiology review. 2017 Apr;6(1):29.
5. Ueshima K, Nakamura Y, Takeno S, Miyake T, Takemura T. Atriofascicular Mahaim with Ebstein anomaly: A case report. Journal of arrhythmia. 2017 Oct;33(5):508-10.
6. Oka K, Seki M, Kataoka K, Sato T, Imai Y, Yamagata T. Percutaneous Atrial Septal Defect Closure in Adult Ebstein’s Anomaly with Exertional Hypoxemia. International Heart Journal. 2020:19-641.
7. Yuan SM. Ebstein’s Anomaly: Genetics, Clinical Manifestations, and Management. PediatrNeonatol. 2017 Jun;58(3):211-215. doi: 10.1016/j.pedneo.2016.08.004. Epub 2016 Nov 19.PMID: 28017577
8. Green CE, Gottdiener JS, Goldstein HA. Atrial septal defect. Semin Roentgenol. 1985 Jul;20(3):214-25. doi: 10.1016/0037-198x(85)90005-7. PMID: 3898390.
9. Moake L, Ramaciotti C. Atrial septal defect treatment options. AACN Clin Issues. 2005 AprJun;16(2):252-66. doi: 10.1097/00044067-200504000-00015. PMID: 15876892.
10. Numan MT, Ali SK. Trans-catheter closure of large secondum atrial septal defects in patients with Ebstein’s malformation of the tricuspid valve: A report of two cases. Heart Views. 2007 Jan 1;8(3):109.
11. Pradhan P, Jain S, Sen S, Dalvi B. Use of cribriform amplatzer septal occluder in the pediatric population: Feasibility, safety, and technical considerations. Annals of Pediatric Cardiology. 2021 Apr;14(2):159.
12. Tal R, Dahud Q, Lorber A. Fenestrated atrial septal defect percutaneously occluded by a single device: procedural and financial considerations. Cardiology and therapy. 2013 Jun;2(1):97-102.